For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Consulting and advisory fees | 170,500 | 38,750 | 67,200 | 81,997.75* |
| Related party consulting fees | 72,000 | 89,000 | 74,000 | 109,500* |
| General and administrative expenses | 58,733 | 28,381 | 24,912 | 77,276.75* |
| Professional fees | 19,818 | 58,628 | 83,997 | 55,279.75* |
| Research and development expense | 29,636 | 16,303 | 53,966 | 17,318.5* |
| Total operating expenses | 350,687 | 231,062 | 304,075 | 341,372.75 |
| Loss from operations | -350,687 | -231,062 | -304,075 | -341,372.75* |
| Amortization of debt discount | 47,319 | 46,637 | 44,031 | 12,751.5* |
| Interest expense | 45,586 | 35,822 | 44,783 | 56,391.5* |
| Loss on extinguishment of debt | - | - | - | -1,208.75* |
| Gain on extinguishment of debt | - | - | - | 0* |
| Change in fair value of convertible bridge loans | - | - | - | 0* |
| Gain on extinguishment of debt | 0 | 0 | 2,743,546 | - |
| Total other expense | -92,905 | -82,459 | 2,654,732 | -70,351.75* |
| Net income (loss) before income tax expense | -443,592 | -313,521 | 2,350,657 | -411,724.5* |
| Income tax benefit (expense) | -24,199 | -15,928 | 124,585 | 0* |
| Net income (loss) | -419,393 | -297,593 | 2,226,072 | -411,724.5* |
| Less net loss attributable to noncontrolling interest | 0 | 0 | 0 | -4,301.75* |
| Net income (loss) attributable to common stockholders | -419,393 | -297,593 | 2,226,072 | -407,422.75 |
| Basic EPS | 0 | 0 | 0 | - |
| Diluted EPS | 0 | 0 | 0 | -0.001 |
| Basic Average Shares | 882,172,810 | 779,770,035 | 716,715,546 | - |
| Diluted Average Shares | 882,172,810 | 779,770,035 | 2,367,087,385 | 620,875,226 |
XERIANT, INC. (XERI)
XERIANT, INC. (XERI)